Biodexa Pharmaceuticals (BDRX) Debt Ratio (2013 - 2025)

Biodexa Pharmaceuticals has disclosed Debt Ratio across 13 years of filings, most recently posting 0.0 for Q4 2025.

• In Q4 2025, Debt Ratio fell 93.18% year-over-year to 0.0; the TTM figure through Dec 2025 stood at 0.0 (down 93.18% YoY), while the FY2025 annual figure was 0.0, down 93.18% from the prior year.
• Debt Ratio came in at 0.0 for Q4 2025 at Biodexa Pharmaceuticals, down from 0.03 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.11 in Q4 2022 to a low of 0.0 in Q4 2025.
• Average Debt Ratio over 5 years is 0.06, with a median of 0.05 recorded in 2024.
• Year-over-year, Debt Ratio surged 123.98% in 2021 and slumped 93.18% in 2025.
• Over 5 years, Debt Ratio stood at 0.06 in 2021, then soared by 90.39% to 0.11 in 2022, then tumbled by 61.03% to 0.04 in 2023, then gained by 11.75% to 0.05 in 2024, then tumbled by 93.18% to 0.0 in 2025.
• Per Business Quant data, the three most recent Debt Ratio figures were 0.0 in Q4 2025, 0.03 in Q2 2025, and 0.05 in Q4 2024.